Why AEHR (NASDAQ:AEHR) Stock Jumped After Earnings: Record Bookings and a 2027 AI Ramp

Aehr Test Systems (NASDAQ:AEHR) jumped sharply after its results because the company did something small caps rarely do: it gave investors a concrete, enormous growth forecast. Aehr makes equipment that tests chips before they ship, and demand for that testing is exploding as AI chips flood the market. Record orders and a bullish 2027 outlook sent the stock soaring, at one point up more than 50% on the day.

What Aehr Actually Does

Aehr makes “burn-in” testing machines. That may sound technical, but the idea is simple.

Before an expensive AI chip goes into a data centre, it has to be tested hard to make sure it will not fail. Aehr’s machines stress-test chips at high temperatures to catch faults early. As AI processors get more expensive and more complex, catching a bad chip before it ships becomes far more valuable, and that is exactly the service Aehr sells.

The shift into AI has been dramatic. For the full financial year, AI-related testing made up about 71% of Aehr’s total revenue. In the latest quarter, AI and silicon photonics work surged to more than 80% of sales. Only a couple of years ago, this was a business built mostly around electric-vehicle chips. Today it is squarely an AI company.

The Numbers That Drove the Jump

Two figures did the work.

First, orders. New bookings reached a record US$60.7 million in the quarter, more than five times the US$11.1 million a year earlier, thanks to big orders for AI and silicon photonics testing. Aehr’s backlog, the orders it has taken but not yet filled, hit a record US$80.6 million at year-end. Including about US$20 million in new orders booked just after the quarter closed, its effective backlog reached US$100.6 million.

Second, and more important, the forecast. Aehr expects revenue of US$130-150 million next year. Against this year’s US$50 million, that is about triple, or growth of 160% to 200%. It also expects to be solidly profitable, with adjusted pre-tax income of 18% to 22% of revenue.

For a company this small, a forecast that big is rare, and it is why the stock reacted so strongly.

What It Means for Investors

The case for Aehr is easy to follow. It is a small company riding one of the strongest trends in technology, its order book is at record levels, and its own forecast points to huge growth next year. Better still, that forecast is backed by real orders already on the books, not just hope, which makes it more believable than a typical small-cap promise.

But the risks are just as real. Aehr’s sales actually fell 15% over the past full year, which shows how up-and-down this business can be. On a reported basis, its annual loss widened to US$7.1 million from US$3.9 million, though it did stay narrowly profitable once one-off items are stripped out, with adjusted net income of US$0.9 million. The company is also dealing with a patent dispute in China, and its rosy forecast depends on customers ramping up production on time, which does not always happen.

Then there is the price. The stock had already climbed more than 250% over the past year before this jump, so a lot of good news is already baked in. Buyers at these levels are paying up for a future that still has to be delivered.

Our take: Aehr is a genuine way to play the AI chip boom further down the supply chain, and next year’s forecast is impressive. But this is a small, volatile stock that swings hard in both directions. The growth is real, the risk is real too, and chasing a one-day spike is rarely the smart way in.